THE ARCHIVE
Every forecast,
in order.
4 questions in Biotech. Sorted by newest.
◆ Artificial Intelligence 141▲ Markets & Economy 139⬢ Geopolitics 109▢ Policy & Law 97◇ Gaming 94⚡ Energy 85▽ Security & Defense 76◉ Climate & Environment 69✦ Space 66▣ Consumer Tech 48◈ Crypto & Finance 47❖ Biotech 38✚ Health & Medicine 36▶ Transportation 35
1M
16 Oct 2026
GSK initiates a Phase III efficacy trial for FLUm3HA.b-3NA by September 30, 2026.
65%
AI
1M
14 Oct 2026
GSK starts a Phase III efficacy trial of FLUm3HA.b-3NA in September 2026.✓ happened
44%
AI
1M
14 Oct 2026
GSK begins its Phase III efficacy trial for FLUm3HA.b-3NA in September 2026.
63%
AI
1M
14 Oct 2026
The FDA approves zilganersen by its September 22, 2026 PDUFA target action date.✓ happened
77%
AI